Tonix Pharmaceuticals Logo

  • About
    • Leadership
      • Executive Team
      • Board of Directors
    • Facilities
    • State Disclosures
  • Therapeutic Areas Overview
    • Central Nervous System
      • Fibromyalgia
      • Migraine
    • Immunology
      • Organ Transplant Rejection
      • Gastro-Intestinal Cancers
    • Infectious Disease
      • Mpox (Monkey Pox)
      • Smallpox
  • Pipeline
    • Central Nervous System
      • TNX-102 SL
    • Immunology
      • TNX-1500
      • TNX-1700
    • Infectious Disease
      • TNX-801
      • TNX-4200 CD45
    • Expanded Access Policy
  • Medicines
  • Clinical Trials
  • News & Events
    • Press Releases
    • Tonix in the News
    • Tonix Sponsored News
    • Investor Presentations
    • Scientific Presentations
    • IR Events
    • Op-eds
  • Investors
    • News & Events
    • Presentations
      • Investor Presentations
      • Scientific Presentations
      • Program Specific Presentations
      • Conference Materials
    • Multimedia
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact Us

Tonix in the News

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • Tonix in the News
    • Tonix Sponsored News
    • IR Events
    • Email Alerts
    • Op-Eds
  • Presentations
  • Multimedia
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • Form 8937
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Tonix in the News
  • Tonix Sponsored News
  • IR Events
  • Email Alerts
  • Op-Eds
Nature Biotechnology | Sep 9, 2022

Monkeypox response relies on three vaccine suppliers

Endpoints News | Aug 24, 2022

'Nothing escapes our scientists': A handful of biotechs gear up work on monkeypox

The Frederick News-Post | Aug 18, 2022

Tonix Pharmaceuticals develops monkeypox vaccine for future by looking at past

BioProcess International | Aug 16, 2022

Tonix looks to live virus vaccines to prevent the spread of monkeypox

New Bedford Guide | Jun 22, 2022

Tonix Pharmaceuticals facility officially opens in the New Bedford Business Park

BioCentury | Jun 14, 2022

Poxvirus agents, by the mechanisms

The New York Times | Jun 3, 2022

21 Americans Infected With Monkeypox, C.D.C. Reports

Bioprocess Online | May 31, 2022

What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D. (Podcast)

Bloomberg | May 2, 2022

Balance of Power: Omicron Subvariant Raises Concerns (Podcast)

FiercePharma | Mar 8, 2022

Mass General plans study of nasally delivered binge eating disorder drug

Clinical Trials Arena | Feb 8, 2022

Long Covid-19: Tonix reveals Phase II trial design plans

HCP Live | Nov 6, 2021

Daily Sublingual Cyclobenzaprine Improves Sleep, Pain Outcomes in Fibromyalgia Patients

Maryland.gov | Oct 20, 2021

Tonix Pharmaceuticals expands into Frederick, Md.

The Frederick News-Post | Oct 18, 2021

New Infectious Disease Research and Development Center Opens in Frederick

WDVM News | Oct 18, 2021

Tonix Pharmaceuticals comes to Frederick

Bloomberg | Aug 23, 2021

FDA Grants Full Approval of Pfizer-BioNTech Vaccine (Podcast)

Boston Business Journal | Aug 9, 2021

Biopharma company Tonix expanding to New Bedford

Pain News Network | Aug 4, 2021

Study of Fibromyalgia Drug Continues Despite Disappointing Results

Boston Globe | Aug 2, 2021

Talking Points: N.J. biotech plans to manufacture vaccines in new Mass. plant

Baltimore Business Journal | Jul 27, 2021

New Jersey pharma company to purchase Frederick R&D facility

rss_feed RSS
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Next Pagearrow_forward
email icon Sign up for Email Alerts
twitter icon linkedin icon facebook icon
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Site Map

© 2025 Tonix Pharmaceuticals Holding Corp.